scispace - formally typeset
H

Hiroto Katoh

Researcher at University of Tokyo

Publications -  77
Citations -  4135

Hiroto Katoh is an academic researcher from University of Tokyo. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 24, co-authored 53 publications receiving 3061 citations. Previous affiliations of Hiroto Katoh include Hokkaido University & National Cancer Research Institute.

Papers
More filters
Journal ArticleDOI

Pan-cancer analysis of whole genomes

Peter J. Campbell, +1332 more
- 06 Feb 2020 - 
TL;DR: The flagship paper of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium describes the generation of the integrative analyses of 2,658 whole-cancer genomes and their matching normal tissues across 38 tumour types, the structures for international data sharing and standardized analyses, and the main scientific findings from across the consortium studies.
Journal ArticleDOI

Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma

TL;DR: The presence of high levels of both CD8+ T cells and CD4- T cells is a significant indicator of a better prognosis for patients with NSCLC, and cooperation between these cell populations may allow a significantly more potent antitumour response than either population alone.
Journal ArticleDOI

Somatic Single Hits Inactivate the X-Linked Tumor Suppressor FOXP3 in the Prostate

TL;DR: Somatic inactivating mutations and deletion of the X-linked FOXP3 gene residing at Xp11.23 in human prostate cancer are reported to represent a paradigm of "single genetic hit" inactivation-mediated carcinogenesis.
Journal ArticleDOI

Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: Identification of genetic indicators that predict patient outcome

TL;DR: The subchromosomal numerical aberrations of 44 surgically resected pancreatic adenocarcinomas were analyzed by array‐based comparative genomic hybridization, suggesting the presence of multiple or complementary mechanisms of evolution in pancreatic cancer.